Skip to Content
Merck
  • CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer.

CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer.

Cellular signalling (2015-04-07)
Guanqiao Wang, Zhenguo Cheng, Funan Liu, Hongyan Zhang, Jiabin Li, Feng Li
ABSTRACT

Carbonic anhydrase IX(CA9)is a member of the carbonic anhydrase family that catalyzes the reversible hydration of carbon dioxide, and plays a key role in the regulation of pH. Although a large number of studies have shown that CA9 is strongly up-regulated by HIF1-α, little is known about the negative regulation mechanism of CA9 in cancer cells. Here we find that CREB is a key negative regulator of CA9 in gastric cancer. Over-expression of CREB can significantly repress the expression of CA9. Treating with anisomycin (ANS), an activator of p38, the phosphorylation and nuclear translocation of CREB are both promoted, while the transcription of CA9 is repressed. Besides, our results firstly identify that CREB can recruit SIRT1 (class III HDACS) by adaptor protein p300, then repress the expression of CA9. These findings may contribute to understand the negative regulation mechanisms of CA9 in gastric cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human EP300
Sigma-Aldrich
MISSION® esiRNA, targeting human NOTCH1
Sigma-Aldrich
8-Anilino-1-naphthalenesulfonic acid
Sigma-Aldrich
L-Glutathione reduced, ≥98.0%
Sigma-Aldrich
L-Glutathione reduced, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
L-Glutathione reduced, BioXtra, ≥98.0%
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Notch1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Ep300